Research & Development

哥哥去在哥哥干哥哥干在曾耗资百亿兴建 青岛世博园被指已经残破“撂荒”


  夏侯靜驚愕的瞅著瑕丘江公道︰“江公真的認為此人膽略不足?”   老虎大王吃肉的時候有一根骨頭卡在喉嚨里了,可憐的大王痛苦的上躥下跳。哥哥去在   箱子里全是書本,火藥一點都看不見了。哥哥干   他覺得自己就是一匹狼,一匹孤獨的狼,而匈奴人就是他要狩獵的羊群。   雲音繼續追問。哥哥干在   曹襄收回凌亂的目光,背著手下了扁舟,施施然的來到一個背對著他的老叟身邊,喘口氣,坐了下來。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo